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Abstract: Pharmacological concentrations of melatonin reduce reperfusion arrhythmias, but less is
known about the antiarrhythmic protection of the physiological circadian rhythm of melatonin.
Bilateral surgical removal of the superior cervical ganglia irreversibly suppresses melatonin
rhythmicity. This study aimed to analyze the cardiac electrophysiological effects of the loss of
melatonin circadian oscillation and the role played by myocardial melatonin membrane receptors,
SERCA2A, TNFα, nitrotyrosine, TGFβ, KATP channels, and connexin 43. Three weeks after bilateral
removal of the superior cervical ganglia or sham surgery, the hearts were isolated and submitted to ten
minutes of regional ischemia followed by ten minutes of reperfusion. Arrhythmias, mainly ventricular
tachycardia, increased during reperfusion in the ganglionectomy group. These hearts also suffered
an epicardial electrical activation delay that increased during ischemia, action potential alternants,
triggered activity, and dispersion of action potential duration. Hearts from ganglionectomized rats
showed a reduction of the cardioprotective MT2 receptors, the MT1 receptors, and SERCA2A. Markers
of nitroxidative stress (nitrotyrosine), inflammation (TNFα), and fibrosis (TGFβ and vimentin) did
not change between groups. Connexin 43 lateralization and the pore-forming subunit (Kir6.1) of KATP
channels increased in the experimental group. We conclude that the loss of the circadian rhythm of
melatonin predisposes the heart to suffer cardiac arrhythmias, mainly ventricular tachycardia, due to
conduction disorders and changes in repolarization.
Keywords: melatonin; superior cervical ganglia; arrhythmia; melatonin receptors; KATP channels;
connexin 43
1. Introduction
Sudden death is the leading cause of cardiovascular mortality worldwide [1]. Sudden cardiac
death varies depending on the prevalence of coronary heart disease, and it has a circadian distribution
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with a peak in the morning hours [2–8]. Preservation of circadian oscillations from the level of
intracellular organelles to the integrated cardiovascular system appears to be essential for maintaining
health and preventing diseases [8–12].
The pineal gland is the main source of the circulating nocturnal melatonin, which impacts
the whole physiology and presents cardioprotective properties [13,14]. The administration of
high pharmacological doses of melatonin protects against oxidative and nitroxidative stress,
arrhythmias, and inflammation, reduces blood pressure, and attenuates metabolic syndrome [15–17].
A cardioprotective role of physiological levels of melatonin has been observed in the clinical scenario,
and it has been tested under experimental conditions using pinealectomy [3,5,6,13,14,18].
The release of melatonin oscillates following a light–dark cycle through a multisynaptic pathway
between the eyes and the pineal gland [19,20]. Light has an inhibitory effect on melatonin secretion
along a path that begins in the retina and modulates the activity of the suprachiasmatic nuclei (SCN),
where the master circadian clock is located [8]. The SCN send efferents that will impact indirectly in the
superior cervical ganglia (SCG), from which sympathetic nerve fibers emerge towards the pineal gland.
We recently reported the metabolic effects of chronic bilateral superior cervical ganglionectomy
(SCGx) in rats [17,19]. This surgical model results in a functional pinealectomy. In fact, bilateral SCGx is a
reliable procedure to prevent the nocturnal activation of the enzyme arylalkylamine-N-acetyltransferase,
irreversibly suppressing melatonin increase during dark hours [17,19].
Melatonin receptors play a significant role in the cardioprotective actions of melatonin [7,21–32].
MT2 knockout mice lost the cardioprotective actions of melatonin against ischemia/reperfusion
injury [24]. Luzindole, a melatonin receptor antagonist, abrogates the antiarrhythmic effects of
melatonin under hypokalemic proarrhythmic conditions [23]. Acute melatonin receptor activation
shortened action potential duration (APD) at 50% of repolarization, but it did not change the duration
at 90% of repolarization or QT interval duration in the ECG during hypokalemia. Anti-adrenergic
actions of melatonin are also blocked by luzindole [21]. Melatonin also reduces calcium overload by
inhibition of inositol trisphosphate receptor expression and promotion of sarco/endoplasmic reticulum
Ca2+-ATPase 2A (SERCA2A) expression via the extracellular-signal-regulated kinase 1 pathway in
cardiomyocytes [33]. ATP-regulated potassium channels (KATP) are involved in ischemia/reperfusion
arrhythmias, and recently, a modulatory effect of melatonin was described for these channels [34–36].
Connexins contribute to electrical coupling and signal propagation across myocardial tissue. We recently
showed that melatonin preserved myocardial connexin 43 distribution and phosphorylation in a
receptor-dependent manner [23]. Chronic melatonin administration preserves connexin topology
and functionality, making the heart more resistant to arrhythmic stimuli [37]. Chronic melatonin
administration at pharmacological levels prevents pro-arrhythmic myocardial remodeling induced by
kidney disease [38,39]. However, the role of melatonin circadian oscillation in these critical proteins
involved in arrhythmogenesis is scarce.
This study aimed to analyze the cardiac electrophysiological effects of the loss of melatonin
circadian oscillation, and the role played by myocardial melatonin membrane receptors, SERCA2A,
TNFα, nitrotyrosine, TGFβ, KATP channels, and connexin 43.
2. Results
2.1. Electrophysiological Effects of SCGx in Isolated Rat Hearts Submitted to Regional Ischemia/Reperfusion
Reperfusion ventricular arrhythmias increased in rat hearts isolated after three weeks of surgical
removal of the superior cervical ganglia (SCGx) (Figure 1). Ventricular premature beats and ventricular
tachycardia were the main types of arrhythmias seen in the SCGx group, while ventricular fibrillation
did not increase after surgeries (2/12 in SCGx and 0/10 in sham). Ventricular tachycardia also lasted
longer in SCGx (median 36 s, IQR 0-66) than in sham hearts (median 0, IQR 0-0, p = 0.0093 by
Mann–Whitney test).
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Figure 1. Hearts from SCGx rats suffered severe reperfusion arrhythmias. (A) Experimental protocol: 
three weeks after bilateral superior cervical ganglionectomy (SCGx) or sham operation, hearts were 
isolated and perfused according to the Langendorff technique. After stabilization, electrocardiograms 
(ECG) and action potentials were recorded during 10 min of preischemia, 10 min of regional 
myocardial ischemia, and 10 min of reperfusion. (B) Representatives ECG from the first 3 min of 
reperfusion. The red marks and their corresponding lowercase letters indicate where the time scale 
was extended to 1 s, and they display the different types of arrhythmias identified. (C) The 
ganglionectomized animals had a higher number of arrhythmias compared to those sham-operated 
(p = 0.03 by Fisher’s exact test). (D) Ventricular tachycardia increased in the SCGx group (p = 0.031 by 
Fisher’s exact test). 
During preischemia, heart rate and ECG intervals (PR, QRS, QT, QTc) did not show differences 
among groups (Figure 2). Ischemia induced progressive bradycardia in both groups. PR interval 
Figure 1. Hearts from SCGx rats suffered severe reperfusion arrhythmias. (A) Experimental protocol:
three weeks after bilateral superior cervical ganglionectomy (SCGx) or sham operation, hearts were
isolated and perfused according to the Langendorff technique. After stabilization, electrocardiograms
(ECG) and action potentials were recorded during 10 min of preischemia, 10 min of regional myocardial
ischemia, and 10 min of reperfusion. (B) Representatives ECG from the first 3 min of reperfusion.
The red marks and their corresponding lowercase letters indicate where the time scale was extended to
1 s, and they display the different t pes of arrhythmias identified. (C) T e ganglionectomized animals
had higher nu ber of arrhyt mias compared to th se sham-operated (p = 0.03 by Fis er’s exact test).
(D) Ventricular tachycardia increased in he SCGx group (p = 0.031 by Fisher’s e act test).
During preischemia, heart rate and ECG intervals (PR, QRS, QT, QTc) did not show differences
among groups (Figur 2). Ischemia induced progres ive bradycardia in both groups. PR interval
dispersed m re in SCGx than in sham hearts du ing i ch mi . QRS ncreased during ischemia and
reached a significant difference at the beginning of reperfusion in the experimental group. QT interval
shortened during the last 5 min of ischemia in SCGx hearts, and this shortening was clearer when QT
intervals were corrected by the heart rate (QTc).
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intervals were corrected by the heart rate (QTc).  
 
Figure 2. Heart rate and ECG intervals during ischemia/reperfusion. (A) Representative ECG from 
the preischemic period. PR, QRS, or QT intervals did not differ between groups. (B) Heart rate 
decreased during ischemia and partially recovered during reperfusion in both groups. (C) PR interval 
showed more dispersion during ischemia in the SCGx group. (D) QRS interval increased during 
ischemia and reached a significant difference at the first minute of reperfusion in the SCGx animals. 
(E) QT interval showed more dispersion during the last minutes of ischemia and the beginning of 
reperfusion in the SCGx group. (F) QTc from SCGx hearts shortened during the last five minutes of 
ischemia. 
Epicardial action potential duration (APD) was longer in SCGx hearts during preischemia, but 
this prolongation did not modify the QT interval duration in the ECG (Figures 2 and 3A). The 
prolongation in APD was significant from 50% of repolarization (Figure 3A).  
Ganglionectomy induced a delay in action potential upstroke respective to the onset of the QRS 
complex during ischemia compared with the sham group (22.1 ± 1.3 ms vs. 12.5 ± 1.2 ms, p < 0.05 by 
Figure 2. Heart ate and ECG intervals during ischemia/rep rfusion. (A) Representative ECG from the
preischemic p riod. PR, QRS, or QT intervals did not iffer between groups. (B) Heart rate decreased
during ischemia and partially recovered during reperfusion in both groups. (C) PR interval showed
more dispersion uring schemia in the SCGx group. (D) QRS interval increased during ischemia and
reached a sig ificant difference at the first minute of reperfusion in the SCGx animals. (E) QT interval
showed mor dispersion during the last minutes of ischemia and the beginning of reperfusio in the
SCGx group. (F) QTc from SCGx hearts shortened during the last five minutes of ischemia.
Epicardial action potential duration (APD) was longer in SCGx hearts during preischemia, but this
prolongation did not modify the QT interval duration in the ECG (Figures 2 and 3A). The prolongation
in APD was significant from 50% of repolarization (Figure 3A).
Ganglionectomy induced a delay in action potential upstroke respective to the onset of the QRS
complex during ischemia compared with the sham group (22.1 ± 1.3 ms vs. 12.5 ± 1.2 ms, p < 0.05 by
repeated measures ANOVA) (Figure 3B). In addition, SCGx hearts suffered a more pronounced action
potential shortening during the last three minutes of ischemia (Figure 3C).
Early after-depolarizations triggered premature ventricular beats only in the SCGx group.
Other types of ectopic activity, like premature junctional complex, occurred in hearts from
ganglionectomized rats (Figure 3D).
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ischemia, action potential (upper trace) activation delayed in respect of the beginning of the QRS 
complex of the ECG (lower trace). This is an indicator of reduced local propagation and suffered 
conduction blockage (2:1) causing repolarization alternants (blue traces correspond to 1 s). (C) Local 
activation delay persisted, and action potential shortened during the last minutes of ischemia, and 
early after-depolarization frequently occurred in SCGx group (blue traces correspond to 1 s). (D) 
During reperfusion, hearts from the sham group displayed early after-depolarizations (indicated by 
the asterisks), but they did not trigger arrhythmias as it can be seen in the ECG (black traces 
correspond to 6 s). In hearts from the SCGx group, early after depolarization triggered premature 
beats. Additionally, junctional complexes were also detected. The absence of P wave and QRS 
morphology like supraventricular activation (green arrows) are assumed to be an escape beat from 
the atrioventricular conduction system. 
2.2. SCGx Reduced the Expression of Myocardial Melatonin Receptors and SERCA2A 
The expression of both melatonin receptors, MT1 and MT2, decreased in cardiomyocytes of hearts 
from the SCGx group (Figures 4 and 5). However, the vascular expression of both receptors remained 
unchanged (red arrows in Figures 4 and 5). In addition, the levels of SERCA2A declined in myocytes 
of ganglionectomized rats.  
Figure 3. Epicardial action potential. (A) Averaged action potentials from preischemic recordings
display a lengthening of 50% of repolarization in cardiomyocytes from SCGx hearts. (B) During ischemia,
action potential (upper trace) activation delayed in respect of the beginning of the QRS complex of the
ECG (lower trace). This is an indicator of reduced local propagation and suffered conduction blockage
(2:1) causing repolarization alternants (blue traces correspond to 1 s). (C) Local activation delay persisted,
and action potential shortened during the last minutes of ischemia, and early after-depolarization
frequently occurred in SCGx group (blue traces correspond to 1 s). (D) During reperfusion, hearts from
the sham group displayed early after-depolarizations (indicated by the asterisks), but they did not
trigger arrhythmias as it can be seen in the ECG (black traces correspond to 6 s). In hearts from the
SCGx group, early after depolarization triggered premature beats. Additionally, junctional complexes
were also detected. The absence of P wave and QRS morphology like supraventricular activation
(green arrows) are assumed to be an escape beat from the atrioventricular conduction system.
2.2. SCGx Reduced the Expression of Myocardial Melatonin Receptors and SERCA2A
The expression of both melatonin receptors, MT1 and MT2, decreased in cardiomyocytes of hearts
from the SCGx group (Figures 4 and 5). However, the vascular expression of both receptors remained
unchanged (red arrows in Figures 4 and 5). In addition, the levels of SERCA2A declined in myocytes of
ganglionectomized rats.
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Figure 4. Melatonin receptor type 1 (MT1) and SERCA2A in myocardial tissue. Confocal 
immunofluorescence microscopy showed that MT1 and SERCA2A decreased in cardiomyocytes from 
the SCGx group (yellow arrows). Vascular expression of MT1 receptors remained unchanged (red 
arrows). Transmitted light (TL) images showed the vascular and myocytic location of MT1 receptors. 
Integrated optical density (IOD) was quantified as the area (>3 pixels connected) multiplied by the 
average intensity. Bars in the right-hand column indicate mean and SEM values relative to the level 
measured in the sham group. The white scale bars in the lower right corners indicate 20 µM. In both 
groups, a total of 18 pictures were analyzed, six from three different hearts. * p < 0.05 and ** p < 0.01 
vs. Sham by unpaired t-test with Welch’s correction. 
Figure 4. Melatonin receptor type 1 (MT1) and SERCA2A in myocardial tissue. Confocal
immunofluorescence microscopy showed that MT1 and SERCA2A decreased in cardiomyocytes
from the SCGx group (yellow arrows). Vascular expression of MT1 receptors remained unchanged (red
arrows). Transmitted light (TL) images showed the vascular and myocytic location of MT1 receptors.
Integrated optical density (IOD) was quantified as the area (>3 pixels connected) multiplied by the
average intensity. Bars in the right-hand column indicate mean and SEM values relative to the level
measured in the sham group. The white scale bars in the lower right corners indicate 20 µM. In both
groups, a total of 18 pictures were analyzed, six from three different hearts. * p < 0.05 and ** p < 0.01 vs.
Sham by unpaired t-test with Welch’s correction.
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Figure 5. Melatonin receptor type 2 (MT2) and SERCA2A in myocardial tissue. The cardioprotective 
MT2 receptors decreased in myocytes from the SCGx group (yellow arrows). MT2 receptors persisted 
in vascular tissue (red arrows). The middle panel is shown to confirm the reduction of SERCA2A in 
the SCGx hearts. Transmitted light (TL) images revealed the vascular and myocytic location of MT2 
receptors. Bars in the right-hand column indicate the mean integrated optical density (IOD) and SEM 
values relative to the level measured in the Sham group. The white scale bars in the lower right 
corners indicate 20 µM. In both groups, a total of 18 pictures were analyzed, six from three different 
hearts. * p < 0.05 and ** p < 0.01 vs. Sham by unpaired t-test with Welch’s correction. 
2.3. SCGx Increased KATP Channels and Connexin 43 Lateralization, Without Changing TNFα or 
Nitrotyrosine 
The pore-forming subunit (Kir6.1) of ATP-regulated potassium channels increased in the SCGx 
hearts (Figure 6). This result is consistent with the action potential and QTc shortening shown in 
Figures 2 and 3. ATP depletion and ADP increase during ischemia; furthermore, oxidative stress and 
acidosis are stimuli for the sulfonylurea receptor subunits that open Kir6.1. 
Tumor necrosis factor α (TNFα), a pro-inflammatory and pro-arrhythmic stimulus, did not 
increase after bilateral SCGx (Figure 6). Indeed, the levels found in myocardial tissue were low in 
both groups. 
Figure 5. Melatonin receptor type 2 (MT2) and SERCA2A in myocardial tis ue. The cardioprotective
MT2 receptors decreased in myocytes from the SCGx group (yellow arrows). MT2 receptors persisted
in vascular tis ue (red ar ows). The mid le panel is shown to confirm the reduction of SERCA2A in
the SCGx hearts. Transmit ed light (TL) images revealed the vascular and myocytic location of MT2
receptors. Bars in the right-hand column indicate the mean integrated optical density (IOD) and SEM
values relative to the l vel measured in the S am group. The white scale bars in the lower right corners
indicate 20 µM. In both groups, a t tal of 18 pictures were analyzed, six from three different hearts.
* p < 0.05 and ** p < 0.01 vs. Sham by unpaired t-test with Welch’s correction.
2.3. SCGx Increased KATP Channels and Connexin 43 Lateralization, without Changing TNFα or Nitrotyrosine
The por -forming subunit (Kir6.1) of ATP-regulated potassium channels increased in the SCGx
hearts (Figure 6). This result is consistent with the action potential and QTc shortening shown in
Figures 2 and 3. ATP depletion and ADP increase during ischemia; furthermore, oxidative stress and
acidosis are stimuli for the sulfonylurea receptor subunits that open Kir6.1.
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Figure 6. The pore-forming subunit (Kir6.1) of KATP and tumor necrosis factor-alpha (TNFα) in SCGx 
rats. Kir6.1 increased in cardiomyocytes from ganglionectomized rats (yellow arrows). The levels of 
the inflammatory marker TNFα were low in ventricular samples of both groups (red arrows). Bars in 
the right-hand column indicate the mean integrated optical density (IOD) and SEM values relative to 
the level measured in the Sham group. The white scale bars in the lower right corners indicate 20 µM. 
In both groups, a total of 18 pictures were analyzed, six from three different hearts. * p < 0.05 vs. Sham 
by unpaired t-test with Welch’s correction. 
Nitrotyrosine is a relatively stable marker of nitroxidative stress that is formed by peroxynitrite 
interaction with tyrosine. Like TNFα, myocardial nitrotyrosine was not affected by chronic SCGx 
(Figure 7).  
Electrical signals propagate between cardiomyocytes through channels formed by connexin 43 
(Cx43), in areas of the cells called intercalated discs (ID). Hearts from the Sham group showed 
abundant levels of Cx43 at ID and fewer signals in the lateral borders of the cardiomyocytes (see red 
arrows in Figure 7). The bilateral SCGx reduced the levels of Cx43 at the ID and increased the lateral 
levels. The total intensity of Cx43 did not change between groups, indicating a lateralization.  
Figure 6. The pore-forming subunit (Kir6.1) of KATP and tumor necrosis factor-alpha (TNFα) in SCGx
rats. Kir6.1 increased in cardiomyocytes from ganglionectomized rats (yellow arrows). The levels of
the inflam atory marker TNFα were low in ventricular samples of both groups (red arrows). Bars in
the right-hand column indicate the mean integrated optical density (IOD) and SEM values relative to
the level measured in the Sham group. The white scale bars in the lower right corners indicate 20 µM.
In both groups, a total of 18 pictures were analyzed, six from three different hearts. * p < 0.05 vs. Sham
by unpaired t-test with Welch’s correction.
Tumor necrosis factor α (TNFα), a pro-inflammatory and pro-arrhythmic stimulus, did not
increase after bilateral SCGx (Figure 6). Indeed, the levels found in myocardial tissue were low in
both groups.
Nitrotyrosine is a relatively stable marker of nitroxidative stress that is formed by peroxynitrite
interaction with tyrosine. Like TNFα, myocardial nitrotyrosine was not affected by chronic SCGx
(Figure 7).
Electrical signals propagate between cardiomyocytes through channels formed by connexin 43
(Cx43), in areas of the cells called intercalated discs (ID). Hearts from the Sham group showed abundant
levels of Cx43 at ID and fewer signals in the lateral borders of the cardiomyocytes (see red arrows
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in Figure 7). The bilateral SCGx reduced the levels of Cx43 at the ID and increased the lateral levels.
The total intensity of Cx43 did not change between groups, indicating a lateralization.
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Figure 7. Myocardial nitroxidative stress and connexin 43 (Cx43) after bilateral SCGx. Nitrotyrosine 
(Nitro) did not change between groups (yellow arrows). Sham hearts showed Cx43 mainly at the 
intercalated discs (ID), and a scarce signal was also observed at the lateral levels of myocytes (red 
arrows). SCGx reduced Cx43 at ID, and most of the signal was located at the lateral borders of the 
myocytes. Bars in the right-hand column indicate the mean integrated optical density (IOD) and SEM 
values relative to the level measured in the Sham group. The white scale bars in the lower right 
corners indicate 20 µM. In both groups, a total of 18 pictures were analyzed, six from three different 
hearts. 
2.4. SCGx Did Not Increase Markers of Fibrosis 
The fibrotic stimulant TGBβ and the fibroblast marker vimentin remained unchanged in both 
sham and SCGx groups (Figure 8). The unphosphorylated connexin 43 at serine 368 that is identified 
by the monoclonal antibody Cx1B1 displayed a perivascular distribution (see yellow arrows in Figure 
8) near to Vim (red arrows) in both groups. 
Figure 7. Myocardial nitroxidative stress and con exin 43 (Cx43) after bilateral SCGx. itrotyrosi e
(Nitro) di not change between groups (yellow arrows). Sham hearts sho ed Cx43 ai l at t e
intercalated iscs (ID), and a scarce signal was also observed at the lateral levels of yocytes (re
arrows). SCGx reduced Cx43 at ID, and most of the signal was located at the lateral bor ers of t e
myocytes. Bars in the right-hand column indicate the mean integrated optical density (I ) an S
values relative to the level measured in the Sham group. The white scale bars in the lower right corners
indicate 20 µM. In both groups, a total of 18 pictures were analyzed, six from three different hearts.
2.4. SCGx Did Not Increase Markers of Fibrosis
The fibrotic stimulant TGBβ and the fibroblast marker vimentin remained unchanged in both
sham and SCGx groups (Figure 8). The unphosphorylated connexin 43 at s rine 368 that is id ntified by
the monoclonal antibody Cx1B1 displayed a perivascu r istribution (see yellow arrows in Figure 8)
near o Vim (red arrows) in both group .
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Figure 8. SCGx did not increase fibrosis. The unphosphorylated connexin 43 detected by the Cx1B1 
antibody was lateralized mainly to the vascular side of the myocytes (yellow arrows), close to 
fibroblast marker vimentin (Vim, red arrows). Sham and SCGx groups showed the same levels of Vim 
and the profibrotic stimulus TGFβ (yellow staining). Bars indicate the mean integrated optical density 
(IOD) and SEM values relative to the level measured in the Sham group. The white scale bars in the 
lower right corners indicate 20 µM. In both groups, a total of 18 pictures were analyzed, six from three 
different hearts. 
  
Figure 8. SCGx did not increase fibrosis. The unphosphorylated connexin 43 detected by the Cx1B1
antibody was lateralized mainly to the vascular side of the myocytes (yellow arrows), close to fibroblast
marker vimentin (Vim, red arrows). Sham and SCGx groups showed the same levels of Vim and
the profibrotic stimulus TGFβ (yellow staining). Bars indicate the mean integrated optical density
(IOD) and SEM values relative to the level measured in the Sham group. The white scale bars in the
lower right corners indicate 20 µM. In both groups, a total of 18 pictures were analyzed, six from three
different hearts.
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3. Discussion
Physiological circadian oscillation of melatonin protects the heart from reperfusion arrhythmias.
Previous studies showed that pinealectomy increased myocardial injury and arrhythmias [6,13,14,40].
Our results confirm the physiological importance of rhythmic melatonin secretion, without removing
the pineal gland or using any antiadrenergic agent. Although bilateral superior cervical ganglionectomy
(SCGx) is a surgical procedure, this technique is less invasive than pinealectomy [17,19]. On the other
hand, SCGx is more selective than a pharmacological adrenergic blockade. In addition to technical
considerations, electrophysiological and molecular mechanisms of arrhythmias were investigated in
young adult Wistar rats subjected to chronic SCGx or sham surgery.
The combination of triggered activity and variability in ventricular activation and repolarization is
an appropriate substrate for the initiation and maintenance of re-entry circuits [41–43]. Epicardial action
potentials revealed higher vulnerability to arrhythmic triggers in hearts from SCGx rats (Figure 3D).
Bilateral ganglionectomy impaired ventricular activation of cardiomyocytes (Figure 3B,C) and also
at the whole heart level, as evidenced in the QRS lengthening during ischemia and reperfusion
(Figure 2D). Finally, the dispersion of QT intervals and QTc shortening during ischemia facilitate
functional re-entrance, as an additional mechanism to explain the increase in ventricular tachycardia
observed in the SCGx group (Figures 1–3).
Triggered activity is strongly related to calcium overload, and it can be attributed to reduced
levels of SERCA2A in our experimental model [33,44]. SERCA2A is the main ATPase responsible
for calcium reuptake at the sarcoplasmic reticulum [45,46]. Other homeostatic mechanisms regulate
calcium, but the SERCA2A reduction described here could be a strong indicator of calcium-triggered
events during ischemia/reperfusion.
The APD prolongation could be related to the loss of melatonin receptors at cardiomyocyte
membranes. Melatonin receptors are coupled to Kir3.x channels, and melatonin receptor activation
shortens the action potential duration [23,47]. However, we recently showed that melatonin-induced
changes on myocardial repolarization were associated with melatonin antioxidative properties but not
with its antiarrhythmic actions [15,48,49]. Our negative results with nitrotyrosine (Figure 7) as a marker
of nitroxidative stress agree with antioxidant been unrelated to antiarrhythmic effects. On the other
side, the increase in the Kir6.1 subunit observed in SCGx hearts (Figure 6) could shorten action potential
under stressful conditions like ischemia, and it could predispose the hearts to re-entrance circuits.
The proarrhythmic effects of SCGx might be related to altered activation and connexin
43 redistribution. Both mechanisms are potential explanations of sustained reperfusion tachycardia.
Conduction disturbances in SCGx hearts could be related to the redistribution of connexin 43,
and the lateralization of unphosphorylated forms of the Cx43 reported here and concurred with
previous studies [23]. Our results are also relevant for other diseases with increased arrhythmic risk
and chronodisruption like coronary artery disease, non-dipping hypertension, sleep apnea, obesity,
and chronic kidney disease [5,10,16]. Especially, connexin 43 lateralization can aggravate pathologies
with diminished conduction velocity due to fibrosis or genetic mutations [37,39,50].
The negative results described here for TNFα and markers of fibrosis are interesting. TNFα is an
inflammatory and proarrhythmic factor [51–53]. Our results indicate that myocardial inflammation is
not a key arrhythmogenic factor in this model because TNFα remained unchanged in ganglionectomized
hearts. The profibrotic TGBβ and the fibroblast marker vimentin did not increase after SCGx, indicating
a functional rather than a structural substrate for the SCGx-induced arrhythmias [15,38,39].
Future research using the SCGx model with or without administration of exogenous melatonin
will help to further understand the potential role of melatonin as an endogenous cardioprotector that
keeps pace with physiological challenges.
4. Materials and Methods
The IAUC of the Faculty of Medicine, National University of Cuyo (Protocol Nº 74/2016-2019)
approved the present study and monitored that experiments were conducted in accordance with the
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National Institutes of Health’s Guide for Care and Use of Laboratory Animals and the Animal Research:
Reporting In Vivo Experiments (ARRIVE) Guidelines.
4.1. Animals
Male Wistar rats were raised until 3 months of age in our colony under a 12 h–12 h light–dark
cycle (with Zeitgeber time 12 (ZT 12) defined as the time of lights off; light intensity averaging 300 lux
at the cage level), in a controlled environment with food and water ad libitum.
4.2. Surgery
Bilateral superior cervical ganglionectomy (SCGx) was performed as previously
described [17,19,20,54]. Briefly, under ketamine/xylazine anesthesia (50 mg/kg of body weight and
5 mg/kg of body weight, respectively), the ventral neck region was shaved and disinfected. A 2.5 cm
vertical incision exposed the salivary glands. After gentle retraction of the glands, the underlying
muscles were uncovered. The carotid triangles served as a reference for SCG identification and removal
after sectioning the sympathetic trunks, the internal carotid nerves, and the external carotid nerves.
For sham-operated animals, the same procedure was performed but the ganglia were not touched nor
removed. SCGx and sham rats were kept in the animal facility for three weeks until their sacrifice
around ZT6 (middle of light phase); ZT when the circulating melatonin levels are expected to be
minimal [55].
4.3. Electrophysiological Studies
4.3.1. Arrhythmias
Ventricular arrhythmias in isolated rat hearts were classified according to the Lambeth
Convention [56]. Ischemia/reperfusion experiments were performed at ZT 6 ± 1 h.
4.3.2. Electrocardiograms and Action Potentials
Cardiac electrograms and transmembrane action potentials from left ventricle epicardial cells
were obtained from isolated rat hearts, as previously described [15,23].
4.4. Confocal Immunofluorescence Microscopy
Hearts for immunostaining were fixed in 4% paraformaldehyde in phosphate-buffered saline at
4 ◦C at the end of the experimental protocol. All the immunohistochemical procedures were performed
as previously described [39]. Sections were stained with the following primary antisera: rabbit
polyclonal anti-MTNR1A (MT1, Origen, TA321735, dilution 1:500), rabbit polyclonal anti-MTNR1B
(MT2, Origen, AP01322PU-N, dilution 1:500), rabbit polyclonal anti-Cx43 (Cx43, Abcam, ab11370,
dilution 1:1000), rabbit polyclonal anti-Kir6.1 (Kir6.1, Thermofisher, PA5-48354, dilution 1:500);
mouse monoclonal anti-SERCA2A (SERCA2A, Abcam, ab2817, dilution 1:500), mouse monoclonal
anti-unphosphorylated connexin 43 at serine 368 (CX-1B1, Thermofisher, #13-8300, dilution 1:200);
mouse monoclonal anti-vimentin (Vimentin, Sigma, V6630 dilution 1:200); mouse monoclonal
anti-nitrotyrosine (3-nitroityrosine, Santa Cruz, sc-32757, dilution 1:200); and mouse monoclonal
anti-TGFβ (TGFβ, Santa Cruz, 3C11). The secondary antisera included anti-rabbit conjugated with
Alexa Fluor 488 and anti-mouse labelled with the Alexa Fluor 405 fluorophore (Jackson ImmunoResearch
Laboratories Inc., West Grove, PA, USA, dilution 1:500). Images were obtained with a Confocal Zeiss
LSM 880 and processed with Zen Blue 2.5 software (Carl Zeiss Microscopy GmbH, 2018). The maximum
intensity of 30 to 50 z stacks were projected and used for the quantitative analysis. Integrated optical
density (IOD) was quantified as the area (>3 pixels connected) multiplied by the average intensity
using ImageProPlus version 4.5, 2001 for windows (Media Cybernetics, Inc., Rockville, MD, USA).
Values of IOD are expressed as mean and SEM relative to the level measured in the Sham group. For all
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the images from both groups, a total of 18 pictures per immunofluorescence channel were analyzed,
six from three different hearts.
4.5. Statistical Analysis
Data were expressed as mean ± SEM. Inferential analysis was performed using ANOVA or
repeated-measures ANOVA, followed by Bonferroni post-test and contingency tables, which were
treated by Fisher exact test, as appropriate. The duration of reperfusion arrhythmias was expressed
as the median and interquartile range (IQR) and analyzed using the Mann–Whitney U test.
Immunofluorescence images were compared by unpaired t-test with Welch’s correction. The GraphPad
Prism version 8.4.0, 2020 for Windows (GraphPad Software, San Diego, CA, USA, www.graphpad.com)
was used for the statistical analysis.
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